Hif Phi | List of Frontiers open access articles

Original Research

Published on 21 Sep 2022

Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia

in Drugs Outcomes Research and Policies

Li Zheng
Ming Liu
Yatong Zhang
Kaihua Zhang
Yanting Gu
Deping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1005225

4,032 views
5 citations

Review

Published on 30 Nov 2023

Efficacy and safety of hypoxia-inducible factor-prolyl hydroxylase inhibitor treatment for anemia in chronic kidney disease: an umbrella review of meta-analyses

in Renal Pharmacology

Song Ren
Xiaoxiu Yao
Yi Li
Ying Zhang
Chao Tong
Yunlin Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1296702

6,343 views
9 citations

Original Research

Published on 18 Dec 2023

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients

in Renal Physiology and Pathophysiology

Ya-Hui Yang
Yishakejiang Saimaiti
Yang Zhao
Wen Tang

Frontiers in Physiology

doi 10.3389/fphys.2023.1279578

2,877 views
4 citations

Review

Published on 23 Dec 2024

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review

in Clinical Research in Nephrology

Yousuf Abdulkarim Waheed
Jie Liu
Shifaa Almayahe
Dong Sun

Frontiers in Nephrology

doi 10.3389/fneph.2024.1511596

4,835 views
2 citations

Original Research

Published on 27 Apr 2018

Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function

in Neuroinflammation and Neuropathy

Xuan Li
Xin-Xin Cui
Ya-Jing Chen
Ting-Ting Wu
Huaxi Xu
Huiyong Yin
Yun-Cheng Wu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2018.00121

15,565 views
72 citations

Systematic Review

Published on 24 May 2023

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

in Renal Pharmacology

Dinghua Chen
Yue Niu
Fei Liu
Yue Yang
Xue Wang
Ping Li
Xiangmei Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1163908

10,379 views
18 citations

Articles

Bibliometric analysis of hypoxia inducible factor prolyl hydroxylase inhibitor in anemia

Efficacy and safety of hypoxia-inducible factor-prolyl hydroxylase inhibitor treatment for anemia in chronic kidney disease: an umbrella review of meta-analyses

Plasma phospholipids profiling changes were associated with the therapeutic response to Roxadustat in peritoneal dialysis patients

The role and clinical implications of HIF-PHI daprodustat in dialysis-dependent and non-dialysis-dependent chronic kidney disease anemic patients: a general review

Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson’s Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function

Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis